← Back to Search

Light Therapy for Postoperative Pain

N/A

Waitlist Available

Led By Mohab Ibrahim, PhD, MD

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Scheduled for elective primary knee replacement surgery

Be older than 18 years old

Must not have

History of chronic pain requiring chronic opioids equal or greater than 90 Morphine Milligram Equivalent (MME)/day

Unanticipated surgical complications, such as prolonged bleeding requiring long hospital stay, infection, dehiscence, and airway complications (anesthesiologist unable to extubate secondary to pulmonary complications)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 week period

Summary

This trial is investigating whether exposure to green light emitting diode (GLED) can reduce postoperative opioid requirements and pain.

Who is the study for?

This trial is for adults over 18 who can read and write English, scheduled for elective knee replacement surgery. It's not suitable for those with colorblindness, severe mental health issues, chronic pain requiring high-dose opioids, or involved in legal cases related to injury compensation.

What is being tested?

The study tests if green LED light therapy (GLED) reduces the need for opioid painkillers by 20% after knee surgery. It also aims to cut post-surgery pain by 30%, lessen pre-surgery anxiety by the same amount, and improve sleep quality before and after the operation.

What are the potential side effects?

Potential side effects are not explicitly listed but may include discomfort or eye strain from using LED lights. Since this is a non-invasive treatment, serious side effects are unlikely compared to drug interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for my first knee replacement surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been taking opioids equal to or more than 90 MME/day for chronic pain.

Select...

I have experienced unexpected complications after surgery, like extended bleeding, infection, or issues with wound healing and breathing.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 week period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 week period

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 week period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Pharmaceutical Preparations

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Active Treatment Group (Green LED)Experimental Treatment1 Intervention

Subjects will be exposed to a Green LED light for 8 weeks prior to surgery, during their hospital stay and for an additional 2 weeks after hospital discharge.

Group II: Control Group (White LED)Placebo Group1 Intervention

Subjects will be exposed to a White LED light for 8 weeks prior to surgery, during their hospital stay and for an additional 2 weeks after hospital discharge.

0 / 3Eligibility criteria met